Japan Unprotected Left Main Coronary artery Disease PCI Strategy On New Generation Stents

Trial Profile

Japan Unprotected Left Main Coronary artery Disease PCI Strategy On New Generation Stents

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 May 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms J-LESSON
  • Most Recent Events

    • 28 Oct 2013 Planned end date added (1 May 2018) as reported by ClinicalTrials.gov record.
    • 07 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 22 Dec 2010 Additional lead trial investigator (Masato Nakamura) identified as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top